Jakub Morze, MD, PhD

Among N=2530 w HeFH or ASCVD on max tolerated LLT with insufficiently low LDL-C (mean 98mg/dl), obicetrapib (CETPi) 10mg po daily v placebo led to 33% lower LDL-C at 3mo www.nejm.org/doi/full/10.... @nejm.org #EAS2025

I couldn’t be more honored by this mention of our study!

ApoB-containing lipoproteins: count, type, size, and risk of coronary artery disease AbstractBackground and Aims. Apolipoprotein B concentration reflects the number of atherogenic lipoproteins and is recognized as a key lipid risk marker. W

🫀 Our new study is now out in #EHJ @escardio.bsky.social

📣 Measuring both #apoB and #LipoproteinA provides the most accurate assessment of cardiovascular risk in primary prevention

doi.org/10.1093/eurh...

I was really curious if Bluesky is included - great to see it’s there 🙌

Congratulations! 🎉

Great collaborative work spearheaded by M. Ardissino showing that, among those sustaining early-onset myocardial infarction, a CAD polygenic risk score was the strongest among assessed predictors of recurrent events www.ahajournals.org/doi/10.1161/... @ahajournals.bsky.social

Our review led by @jsdron.bsky.social of the contributions of the Global Lipids Genetics Consortium (www.lipidgenetics.org) journals.lww.com/co-lipidolog...

Congrats Erin! 👏👏👏

Welcome! #CardioSky for sure! 🙌

Excited to share our latest in Nature Cardiovascular Research
led by ⭐️ @artschuermans.bsky.social ! #CardioSky #MedSky

Open access paper here: www.nature.com/articles/s44...

Great thread from Art below 👇

Figure showing percent changes in lipoprotein(a).

Zerlasiran, a small-interfering RNA, reduced time-averaged lipoprotein(a) concentrations by more than 80% during 36 weeks of treatment in patients with atherosclerotic cardiovascular disease. #AHA24

https://ja.ma/4fSsXYX

The Duff lecture is underway! Come join us in S105 for an incredible perspective on the history and future directions of lipoprotein research by the legendary Alan Remaley @ahascience.bsky.social #AHA24 💯

Page one from the Editor's Note "The Fine Art and Science of Translating Trials Results Into Clinical Practice"

Invited Commentary on the FINEARTS-HF trial:

The Fine Art and Science of Translating Trials Results Into Clinical Practice

#AHA24

Read it now in JAMA Cardiology: https://ja.ma/4ex15bP

Natural Language Processing to Adjudicate Heart Failure Hospitalizations in Global Clinical Trials

www.ahajournals.org/doi/10.1161/...
#Circulation #AHA24 #CardioSky #MesSky
@ahajournals.bsky.social @ahascience.bsky.social

Why precision cardiology needs to improve ❤️‍🩹

„CHD PRSs that performed similarly at the population level demonstrated highly variable individual-level estimates of risk”

#CardioSky #MedSky #AHA24

#AHA24 #CardioSky #MedSky

I am 🍾

Great panel discussion ongoing at the AHA Women in Cardiology luncheon. #AHA24 #AHAWIC
@ahascience.bsky.social

A towering pioneer who has shaped the very foundations of modern #cardiology with unwavering brilliance and dedication - a true inspiration to generations 🌟🫀
#CardioSky #AHA24 @ahascience.bsky.social
📷: #TIMI group

Another incredible win for GLP-1RA/GIP Tirzepatide in SUMMIT! 38% reduction in CVD death/worsening HF and improved patient-reported outcomes. Time for policy change to get these therapies to patients with #obesity #hfpef #aha2024 #cardiosky

Excited to be at #AHA24! Please check out our short presentation tomorrow on the role of LV anisotropy in the outcome of MI. www.ahajournals.org/doi/abs/10.1...

Welcome to #MedSky and #EpiSky (+ other skies I forgot about)! 🙌

Joy & 🙏@ahascience.bsky.social #Science #Communicators #AHA24

Such fun team🙌
@dramitkhera.bsky.social
@pnatarajanmd.bsky.social
@vietheartpa.bsky.social
@moradishayan.bsky.social
@seanmwu.bsky.social
@garimasharmamd.bsky.social
@shelbycarignan.bsky.social
@joslynh.bsky.social & ++ #CardioSky

In the first sec, that b&w photo gave me a mild TIA 😣

Welcome to societies/journals joined 🦋👇 #AHA24 #CardioSky

ACC @accintouch.bsky.social
AHA Sciences @ahascience.bsky.social
AHA Journals @ahajournals.bsky.social
JAMA @jamacurrent.bsky.social
ASPC @aspcardio.bsky.social
Am J Prev Card @ajpcardio.bsky.social
J Card Fail @jcardfail.bsky.social

Statins are effective in reducing anthracycline-related cardiac dysfunction. Read more at ow.ly/rlzA50TXw0z

When reserve engineering of #GRADE goes wrong 🤨:

“The criteria for a highly suggestive association were met if: P<10−6, >1,000 participants, and largest study in the meta-analysis presented a nominally significant estimate (i.e., P<.05)”

Where is #ESC? 😄

Engage with the editors of #AHAJournals every day at #AHA24! These interactive sessions will provide invaluable insights into the latest trends, future directions, and the editorial process.

Go to www.ahajournals.org/AHASessions and mark your calendars today!

Hope to see all of #cardiosky at #AHA24